SCHEMBL23830356

SCHEMBL23830356

Cc1cnc2c(C(=O)O)nn(Cc3ncnc(N4CCOCC4)c3C)c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 6/20 0.36
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 4/20 0.36
HPGD P15428 2/20 0.36
GLA P06280 1/20 0.36
HSD17B10 Q99714 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HIF1A Q16665 1/20 0.36
KMO O15229 1/20 0.35
PIK3C2B O00750 5/20 0.35
LRRK2 Q5S007 1/20 0.35
GAA P10253 1/20 0.34
PKM P14618 1/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23830339 0.89 ALOX15 (0.41) ALDH1A1KDM4EHSD17B10SMN1; SMN2GAA
SCHEMBL23830355 0.85 PDE6D (0.35) PDE10AALDH1A1KDM4EHPGDGLA
SCHEMBL23830408 0.79 PDE6D (0.38) PDE6DPDE6APDE6GPDE6BPDE6C
SCHEMBL23830325 0.78 PDE6D (0.37) PDE6DPDE6APDE6GPDE6BPDE6C
SCHEMBL23830276 0.78 PDE6D (0.54) ALDH1A1HSD17B10GAAPKMPDE6D
SCHEMBL23830370 0.77 PDE6D (0.44) PDE6DPDE6APDE6GPDE6BPDE6C
SCHEMBL23830318 0.76 PDE6D (0.41) PDE6DPDE6APDE6GPDE6BPDE6C
SCHEMBL23830379 0.75 PDE6D (0.47) PDE6DPDE6APDE6GPDE6BPDE6C
SCHEMBL23830352 0.69 PDE6D (0.44) ALDH1A1HSD17B10LMNASMN1; SMN2PDE6D
SCHEMBL23830349 0.69 PDE6D (0.38) ALDH1A1KDM4EHSD17B10LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210292333-A1 CONDENSED AZAHETEROARYL COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY AGAINST TUBERCULOSIS BACTERIA CADILA HEALTHCARE LIMITED (IN) 2021-09-23 US disclosed
CN-112543757-A Condensed azaheteroaryl compounds having antibacterial activity against tubercle bacillus 卡迪拉保健有限公司 2021-03-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292333-A1 CONDENSED AZAHETEROARYL COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY AGAINST TUBERCULOSIS BACTERIA DPEP1, SAT1, PEPD PDE10A 2173/4885ALDH1A1 152/4885KDM4E 1380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.